Favorable Pharmacokinetic Characteristics of Extended-Half-Life Recombinant Factor VIII BAY 94-9027 Enable Robust Individual Profiling Using a Population Pharmacokinetic Approach

BACKGROUND: Prophylaxis with factor VIII (FVIII) should be individualized based on patient characteristics, including FVIII pharmacokinetics. Population pharmacokinetic (popPK) modeling simplifies pharmacokinetic studies by obviating the need for multiple samples. OBJECTIVE: The objective of this st...

Descripción completa

Detalles Bibliográficos
Autores principales: Solms, Alexander, Iorio, Alfonso, Ahsman, Maurice J., Vis, Peter, Shah, Anita, Berntorp, Erik, Garmann, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217814/
https://www.ncbi.nlm.nih.gov/pubmed/31749076
http://dx.doi.org/10.1007/s40262-019-00832-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217814/
https://www.ncbi.nlm.nih.gov/pubmed/31749076
http://dx.doi.org/10.1007/s40262-019-00832-7

Ejemplares similares